ASX:EMV EMVision Medical Devices (EMV) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About EMVision Medical Devices Stock (ASX:EMV) 30 days 90 days 365 days Advanced Chart Get EMV alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume192,157 shsAverage VolumeN/AMarket CapitalizationA$165.05 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview EMVision Medical Devices Ltd engages in the research, development, and commercialization of imaging and diagnostic technology products. It develops a portable brain scanner for stroke diagnosis and monitoring, as well as other medical imaging needs. The company was incorporated in 2017 and is based in Macquarie Park, Australia. Read More Receive EMV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EMVision Medical Devices and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EMV Stock News HeadlinesEMVision Medical Devices Full Year 2025 Earnings: Revenues Beat Expectations, EPS LagsAugust 29 at 9:53 PM | finance.yahoo.comEMVision Advances Stroke Diagnostic Tools with Promising Trial ResultsAugust 28 at 2:10 AM | tipranks.comBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.August 30 at 2:00 AM | Banyan Hill Publishing (Ad)EMVision readies UCLA Health as final pivotal trial site for emu stroke detection deviceAugust 26, 2025 | msn.comEMVision Advances Stroke Diagnosis Trials with UCLA ActivationAugust 26, 2025 | msn.comBiocurious: Clinical trial readouts show road to approval can be as exciting as the destinationAugust 19, 2025 | msn.comThis ASX healthcare stock could be a buy low bargainAugust 19, 2025 | msn.comEMVision Advances First Responder Brain Scanner Program with Key MilestonesJuly 29, 2025 | msn.comSee More Headlines EMV Stock Analysis - Frequently Asked Questions How were EMVision Medical Devices' earnings last quarter? EMVision Medical Devices Ltd (ASX:EMV) posted its earnings results on Tuesday, February, 26th. The company reported ($4.47) EPS for the quarter. EMVision Medical Devices had a negative trailing twelve-month return on equity of 22.53% and a negative net margin of 24.33%. Company Calendar Last Earnings2/26/2019Today8/29/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:EMV CIKN/A Webwww.emvision.com.au Phone61 2 8667 5337FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$2.73 million Net Margins-24.33% Pretax MarginN/A Return on Equity-22.53% Return on Assets-7.95% Debt Debt-to-Equity Ratio15.66 Current Ratio6.40 Quick Ratio8.04 Sales & Book Value Annual SalesA$11.22 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow8.47 Book ValueA$0.22 per share Price / BookN/AMiscellaneous Outstanding Shares85,520,000Free FloatN/AMarket CapA$165.05 million OptionableNot Optionable Beta1.47 Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (ASX:EMV) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EMVision Medical Devices Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share EMVision Medical Devices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
